SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-100408
Filing Date
2021-08-05
Accepted
2021-08-05 07:05:25
Documents
14
Period of Report
2021-08-05
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2124043d1_8k.htm   iXBRL 8-K 26970
2 EXHIBIT 99.1 tm2124043d1_ex99-1.htm EX-99.1 249837
6 GRAPHIC tm2124043d1_ex99-1img001.jpg GRAPHIC 11532
  Complete submission text file 0001104659-21-100408.txt   494636

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA irwd-20210805.xsd EX-101.SCH 3206
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE irwd-20210805_lab.xml EX-101.LAB 34593
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE irwd-20210805_pre.xml EX-101.PRE 22724
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2124043d1_8k_htm.xml XML 3629
Mailing Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110
Business Address 100 SUMMER STREET, SUITE 2300 BOSTON MA 02110 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34620 | Film No.: 211146253
SIC: 2834 Pharmaceutical Preparations